glp 1 alzheimer's disease GLP-1R agonists protect against by rewiring energy regulation Alzheimer's trial exposes GLP-1 limits

00:00:58 Narrator Lets take a closer look

No significant changes in any of these safety markers were detected

Primary research: Sexual dysfunction, melanocortin receptor activation Mechanism: Activates melanocortin-4 receptors (MC4R) in the central nervous system, distinct from PDE5 inhibitors like sildenafil Regulatory status: FDA-approved as Vyleesi (2019) for HSDD in premenopausal women Key distinction: Works through CNS melanocortin pathways rather than vascular mechanisms SS-31 / Elamipretide (Mitochondrial Peptide) SS-31 (Elamipretide) is a synthetic tetrapeptide that selectively targets the inner mitochondrial membrane by binding cardiolipin

1 2 "Vitamin C"

In the pancreas, GLP-1 peptides boost insulin secretion and suppress production of glucagon